Keynote speaker
Professor, Harvard Medical School
Stuart Schreiber, Harvard Medical School, gave a keynote at 9th TPD & Induced Proximity Summit (Boston, United States of America, 26–29 Oct 2026) in the session “Principles Underlying Induced Proximity Drugs: Lessons from Early Development to the Present”.
26–29 Oct 2026Boston, United States of America
President & Chief Executive Officer, Arvinas, Inc.
Director, Oncology Search & Evaluation, Business Development & Licensing, Merck & Co
Associate Director, Medicinal Chemistry, AstraZeneca
Science Partner, Flagship Pioneering
Chief Business Officer, Nurix Therapeutics, Inc.
Co-Founder & Chief Technology Officer, Sibylla Biotech srl
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Stuart Schreiber, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].